Related Experiment Video
Updated: Jan 7, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Causal link between coronary heart disease and lipidomics: A Mendelian randomization analysis
Ruixiang Kang1, Dong Guo1, Jiabao Zhang1
1The First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan, China.
None:
The study aims to employ the 2-Sample Mendelian Randomization (MR) and Multivariable MR (MVMR) approaches to investigate the associations between specific lipid profiles and the risk of coronary heart disease (CHD). This study analyzed a comprehensive genome-wide association studies dataset comprising 179 lipidomic traits to assess the associations between various molecular subclasses of lipid traits and the risk of CHD. Causal relationships were investigated using the two-sample Mendelian randomization method, with supplementary analyses, including sensitivity analyses and MVMR, further refining the results. Heterogeneity and horizontal pleiotropy were evaluated using Cochran Q, the MR-Egger intercept test, and MR-PRESSO. Additionally, a leave-one-out sensitivity analysis was conducted to assess the influence of individual single nucleotide polymorphisms on the robustness of MR estimates. By examining 179 lipidomic traits as exposures and CHD as the outcome, this study identified significant causal relationships between glycerophospholipids, sphingolipids, and glycerolipids, which were associated with an increased risk of CHD. Specifically, levels of 5 triacylglycerols (TAGs) - (50:4), (52:3), (52:4), (52:5), and (56:5) - along with 2 phosphatidylethanolamines (PEs), namely (16:0_20:4) and (18:0_20:4), and 1 phosphatidylcholine (PC), namely (O-16:2_18:0), across 3 lipid categories were associated with an increased risk of CHD. The results of this study suggest that increased levels of TAGs, PEs, and PCs are associated with an elevated risk of CHD, implying that these lipid molecules may play a critical role in the pathogenesis of CHD. Furthermore, this study further elucidates the complex lipid metabolic pathways in CHD, highlighting structural alterations in distinct lipidomes that may differentially influence molecular subtypes.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease II: Pathophysiology
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipid Catabolism
